(Q37897691)

English

Amyloid imaging

scientific article published on September 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 August 2017

1 reference

Europe PubMed Central

Amyloid imaging (English)

1 reference

Europe PubMed Central

25 August 2017

amyloid imaging

0 references

author name string

Victor L Villemagne

1

1 reference

Europe PubMed Central

25 August 2017

Christopher C Rowe

2

1 reference

Europe PubMed Central

25 August 2017

publication date

1 September 2011

1 reference

Europe PubMed Central

25 August 2017

International Psychogeriatrics

1 reference

Europe PubMed Central

25 August 2017

23 Suppl 2

1 reference

Europe PubMed Central

25 August 2017

S41-9

1 reference

Europe PubMed Central

25 August 2017

Amyloid PET Ligands for Dementia

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans.

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia.

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography.

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

Use of Florbetapir-PET for Imaging β-Amyloid Pathology

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

Biomarkers for early detection of Alzheimer pathology

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

Accuracy of early diagnosis and its impact on the management and course of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

Frequency of stages of Alzheimer-related lesions in different age categories

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

Imaging of amyloid beta in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

Frequent amyloid deposition without significant cognitive impairment among the elderly

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

Imaging beta-amyloid burden in aging and dementia.

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration.

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

Mild cognitive impairment: current research and clinical implications

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

Evaluating atypical dementia syndromes using positron emission tomography with carbon 11 labeled Pittsburgh Compound B.

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

Visual assessment versus quantitative assessment of 11C-PIB PET and 18F-FDG PET for detection of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

A lipophilic thioflavin-T derivative for positron emission tomography (PET) imaging of amyloid in brain

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18)

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

Characterization of AZD4694, a novel fluorinated Abeta plaque neuroimaging PET radioligand

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

11C-PiB PET studies in typical sporadic Creutzfeldt-Jakob disease.

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

Imaging of amyloid burden and distribution in cerebral amyloid angiopathy.

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

High striatal amyloid beta-peptide deposition across different autosomal Alzheimer disease mutation types

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

[(11)C]-PIB imaging in patients with Parkinson's disease: preliminary results.

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

The ART of loss: Abeta imaging in the evaluation of Alzheimer's disease and other dementias

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

Abeta deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

Detection of Alzheimer pathology in vivo using both 11C-PIB and 18F-FDDNP PET.

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

Identifiers

10.1017/S1041610211000895

1 reference

Europe PubMed Central

25 August 2017

1 reference

Europe PubMed Central

25 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37897691&oldid=1733152977"